Stenotrophomonas
| Stenotrophomonas spp. | |
| Xanthomonadaceae | |
| Stenotrophomonas | |
| Stenotrophomonas in Gram stain | |
| Morphology | G-sticks |
|---|---|
| Relation to oxygen | aerobic |
| Cultivation | MacConkey agar |
| Occurrence | soil, water, plants |
| Disease | respiratory infections, ventilated pneumonia and cystic fibrosis patients, early infections, urinary tract infections |
| Therapy | co-trimoxazole, rifampicin, doxycycline |
| MeSH ID | D020588 |
The genus Stenotrophomonas belongs to the so-called gram-negative non-fermenting bacteria , this group includes genera showing similar characteristics as this genus, they are the genus Pseudomonas and the genus Burkholderia . Due to their common characteristics and traits, these genera can be put into context, in the medical sense, these genera are important mainly in terms of nosocomial diseases .
Taxonomy[edit | edit source]
The taxonomy of the genus Stenotrophomonas is constantly renewed, the current classification is as follows:
- class Gammaproteobacteria
- order Xanthomonadales
- family Xanthomonadaceae
- genus Stenotrophomonas
- species - there are several species, the most risky representative is considered a bacterium - Stenotrophomonas maltophilia
Characteristics[edit | edit source]
This genus is characterized by delayed biochemical activity. Furthermore, they do not stain in the oxidase test , so they are oxidase negative. Like the previous genus Pseudomonas , the genus Stenotrophomonas is the cause of nosocomial infections .
Important representatives[edit | edit source]
Stenotrophomonas maltophilia is considered to be the most risky representative of the genus Stenotrophomonas . It is highly resistant to most anti-pseudomonad drugs, such as aminoglycosides , ceftazidime or piperacillin . In contrast, fluoroquinolones and cotrimoxazole are effective against it .
Links[edit | edit source]
Related articles[edit | edit source]
Reference[edit | edit source]
- BENEŠ, Jiří. Infectious medicine. 1st edition. Prague: Galén, 2009. pp. 252. ISBN 978-80-7262-644-1 .
References[edit | edit source]
- POVÝŠIL, Ctibor and Ivo ŠTEINER, et al. General pathology. 1st edition. Prague: Galén, 2011. 290 pp. Chapter 13: General Oncology. pp. 133-190. ISBN 978-80-7262-773-8 .
- VOTAVA, Miroslav, et al. Medical microbiology special. 1st edition. Brno: Neptun, 2003. 495 pp. Chapter 1.1: Gram-negative non-fermenting bacteria. pp. 29-37. ISBN 80-902896-6-5 .
- KAYSER, Fritz H. and Kurt A. BIENZ. Medical Microbiology. 1st edition. Germany: Thieme, 2005. 268 pp. 308-311. ISBN 9781588902450 .
- SEDLÁK, Kamil and Markéta TOMŠÍČKOVÁ. Dangerous infections of animals and humans. 1st edition. Prague: Scientia, 2006. 167 pp. 147-148. ISBN 80-86960-07-2 .
- HØIBY, Niels. Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis. BMC Medicine [online] . 2011, vol 9, no. 1, p. 32, also available from < https://bmcmedicine.biomedcentral.com/articles/10.1186/1741-7015-9-32 >. ISSN 1741-7015. DOI: 10.1186 / 1741-7015-9-32 .
- NCBI. Taxonomy Browser [online]. [feeling. 2013-3-3]. < https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi >.
- Pathema. Burkholderia [online]. [feeling. 2013-3-3]. < https://www.jcvi.org/cms/research/past-projects/pathema/overview/?page=burkholderia_description >.
Category :
